Simon Pedder, President and CEO at Cellectar Biosciences, Inc. (CLRB), bought 13,300 shares at $3.75 ($50K) on 2014-08-20, disclosed to the SEC on 2014-08-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ATNX | BUY | 2018-11-14 | $30K | — | Filing → |
| ATNX | BUY | 2017-07-28 | $11K | — | Filing → |
| CHTP | BUY | 2010-09-07 | $5K | — | Filing → |